Skip to main content
. 2007 Mar 17;8(2):123–135. doi: 10.1007/s10198-007-0039-4

Table 2.

Mean (SE) exacerbation probabilities in the base-case scenario. (These probabilities were also used in scenario 2. In scenario 3 the probabilities of ipratropium were also applied to tiotropium and salmeterol during years 2 to 5)

  Probability of experiencing an exacerbation Probability that the exacerbation will be severe, given that there is an exacerbation
Tiotropium Salmeterol Ipratropium Tiotropium Salmeterol Ipratropium
Moderate 0.051 (0.004) 0.057 (0.013) 0.080 (0.020) 0.097 (0.024) 0.030 (0.031) 0.267 (0.114)
Severe 0.075 (0.003) 0.089 (0.011) 0.097 (0.013) 0.136 (0.018) 0.138 (0.033) 0.188 (0.041)
Very severe 0.096 (0.005) 0.104 (0.016) 0.102 (0.022) 0.192 (0.027) 0.207 (0.048) 0.186 (0.062)